What are the key pathophysiological differences between congestive cardiomyopathy with systolic failure (CCP) and restrictive cardiomyopathy (RCM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Key Pathophysiological Differences Between Dilated Cardiomyopathy (DCM) and Restrictive Cardiomyopathy (RCM)

DCM is fundamentally a disease of systolic dysfunction with ventricular dilation and impaired contractility, while RCM is characterized by markedly stiff ventricular walls with restrictive filling, reduced diastolic volume, and preserved or near-normal systolic function. 1

Core Pathophysiological Mechanisms

Dilated Cardiomyopathy (DCM)

  • Primary defect: Impaired myocardial contractility leading to systolic dysfunction
  • Ventricular geometry: Progressive chamber dilation with thin walls
  • Ejection fraction: Reduced (typically <40%)
  • Filling pattern: Elevated filling pressures develop secondary to systolic failure
  • Wall thickness: Normal or thin ventricular walls
  • Cardiac output: Reduced due to poor contractile function 2, 3

Restrictive Cardiomyopathy (RCM)

  • Primary defect: Markedly increased myocardial stiffness from fibrosis, infiltration, or endomyocardial scarring
  • Ventricular geometry: Non-dilated ventricles with reduced diastolic volume
  • Ejection fraction: Normal or near-normal (until late stages)
  • Filling pattern: Rapid early diastolic filling with abrupt cessation due to rigid walls—the "dip and plateau" or "square root" sign on catheterization
  • Wall thickness: Often increased (especially in infiltrative causes like amyloidosis)
  • Cardiac output: Initially preserved but dependent on elevated filling pressures 1, 4

Hemodynamic Distinctions

RCM demonstrates restrictive physiology with rapid rise in ventricular pressure with minimal volume increase, whereas DCM shows elevated pressures primarily from volume overload and systolic failure 4.

Specific Hemodynamic Features in RCM:

  • Left ventricular filling pressure typically exceeds right ventricular filling pressure by >5 mmHg (can be revealed by exercise or Valsalva)
  • Both systemic and pulmonary venous pressures frequently >50 mmHg
  • Marked biatrial enlargement disproportionate to ventricular size
  • Kussmaul's sign (paradoxical rise in jugular venous pressure with inspiration) is common 1

Specific Hemodynamic Features in DCM:

  • Elevated filling pressures develop as consequence of systolic dysfunction
  • Ventricular dilation with increased end-diastolic and end-systolic volumes
  • Reduced stroke volume and cardiac output
  • Secondary mitral regurgitation from annular dilation 2

Underlying Pathology

DCM Pathology:

  • Myocyte loss and replacement fibrosis
  • Disrupted sarcomeric proteins (in genetic forms)
  • Viral myocarditis sequelae (in some cases)
  • Toxic injury (alcohol, chemotherapy)
  • The myocardium is primarily dysfunctional rather than infiltrated 3, 5

RCM Pathology:

  • Infiltrative: Amyloid deposition (most common cause), sarcoidosis
  • Storage diseases: Hemochromatosis, Fabry disease, glycogen storage diseases
  • Endomyocardial: Endomyocardial fibrosis, hypereosinophilic syndrome
  • Idiopathic: Interstitial fibrosis without identifiable cause
  • The myocardium is stiffened by extracellular infiltration or intracellular storage material 1, 4

Clinical Presentation Differences

Both present with heart failure symptoms, but the patterns differ significantly:

DCM Presentation:

  • Progressive exertional dyspnea and fatigue from low cardiac output
  • Symptoms of systolic heart failure predominate
  • Apex beat displaced laterally and diffuse
  • S3 gallop common (volume overload)
  • Cardiomegaly on chest x-ray 2, 3

RCM Presentation:

  • Right-sided heart failure symptoms often disproportionate to systolic function
  • Hepatomegaly, ascites, peripheral edema prominent early
  • Apex beat usually palpable and not displaced (unlike constrictive pericarditis)
  • S3 and/or S4 gallops may both be present
  • Normal heart size or only mild cardiomegaly on chest x-ray
  • Kussmaul's sign frequently present 1

ECG Differences

DCM:

  • Left bundle branch block common (poor prognostic sign)
  • Low voltage less common
  • Q waves may suggest prior infarction in ischemic cardiomyopathy 3

RCM:

  • Low voltage despite increased wall thickness (especially in amyloidosis)
  • Bundle branch block or intraventricular conduction delay
  • Poor R wave progression mimicking infarction
  • Atrioventricular conduction abnormalities (poor prognosis)
  • Atrial fibrillation very common 1

Echocardiographic Distinctions

DCM:

  • Dilated left ventricle with reduced ejection fraction
  • Global hypokinesis
  • Thin or normal wall thickness
  • Functional mitral regurgitation from annular dilation 2

RCM:

  • Small ventricular chambers with normal or increased wall thickness
  • Massive biatrial enlargement (hallmark finding)
  • Normal or near-normal ejection fraction (until late)
  • Thickening of valvular apparatus and interatrial septum
  • Restrictive mitral inflow pattern (E/A ratio >2)
  • Tissue Doppler: E' velocity <8 cm/s at mitral annulus (highly specific for RCM vs. constrictive pericarditis) 6
  • Pericardial effusion common 1, 7

Therapeutic Implications

DCM Treatment:

  • ACE inhibitors/ARBs and beta-blockers are cornerstone therapy (improve mortality)
  • Diuretics for volume management
  • Digoxin for symptomatic benefit
  • ICD for primary prevention if EF ≤35%
  • Cardiac resynchronization therapy if LBBB present
  • Heart transplantation for refractory cases 2, 3

RCM Treatment:

  • Diuretics must be used cautiously—patients are preload-dependent
  • Vasodilators, calcium channel blockers, and nitrates are poorly tolerated and associated with increased side effects
  • Digitalis should be used very carefully (patients with amyloidosis are extremely sensitive)
  • ACE inhibitors have limited proven benefit
  • Positive inotropes are not useful (systolic function is preserved)
  • Focus on volume control and heart rate management
  • Disease-specific therapy when available (iron chelation, enzyme replacement for Fabry disease)
  • Heart transplantation for refractory symptoms 1

Critical Diagnostic Pitfall

The most important clinical distinction is differentiating RCM from constrictive pericarditis, as the latter is surgically curable. Key differentiating features include:

  • Apex beat palpable in RCM but not in constriction
  • Tissue Doppler E' velocity <8 cm/s favors RCM (preserved in constriction)
  • Ventricular interdependence more pronounced in constriction
  • Pericardial thickening on CT/MRI confirms constriction 1, 8, 9, 10

Prognosis

DCM prognosis has improved significantly with modern therapy (ACE inhibitors, beta-blockers, devices), with many patients achieving near-normal life expectancy if diagnosed early 3.

RCM carries a generally poor prognosis with inevitable symptomatic progression and high mortality, particularly in cardiac amyloidosis (median survival <1 year for AL amyloidosis with heart failure) 1.

References

Research

Restrictive cardiomyopathy: definition and diagnosis.

European heart journal, 2022

Research

Hemodynamics of constrictive pericarditis and restrictive cardiomyopathy.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2020

Research

Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics.

Journal of the American College of Cardiology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.